BrainWeb provides information and links to validated sites about brain diseases and disorders from outside sources and from Dana publications.
The Dana Alliance for Brain Initiatives' Successful Aging & Your Brain program includes live public forums, printed and printable resources, and videos.
Reviews by eminent neuroscientists of specific areas of research, including normal function, disease, and new technologies.
Briefing Papers take an in-depth look at basic and timely brain-related topics, like traumatic brain injury and obesity.
Researchers investigate an FDA-approved diabetes drug
that affects effect on energy production in cells.
Treating inherited retinal disease and deafness are likely near-term
Synaptic-level changes encode memories in the short
term. Could changes at the synapse-support structure, the PNN, encode
(Read Q&A with Richard S. Jope, Ph.D.)
The element lithium is given in capsule form as a mood stabilizer for bipolar disorder and depression. New research, however, reveals its role as a neuroprotector, and suggests that enzymes modulated by lithium could lead to new treatments for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and other neurodegenerative disorders.
DNA damage and repair
are widely studied by cancer biologists and immunologists; now neuroscientists
are taking a look
(Read Q&A with Michael H. Baumann, Ph.D.)
Recent data indicate that 540 different drugs classified as new
psychoactive substances (NPS) have been identified worldwide as of 2014, and
this number is expected to rise. Our article describes the complexity of the
NPS problem, what is known about the molecular mechanisms of action, and highlights some of the considerable challenges in
dealing with this emerging issue.